227 related articles for article (PubMed ID: 27886588)
21. Stereotactic ablative body radiosurgery (SABR) or Stereotactic body radiation therapy (SBRT).
Folkert MR; Timmerman RD
Adv Drug Deliv Rev; 2017 Jan; 109():3-14. PubMed ID: 27932046
[TBL] [Abstract][Full Text] [Related]
22. The role of immunotherapy in combination with oligometastasis-directed therapy: a narrative review.
Turchan WT; Chmura SJ
Ann Palliat Med; 2021 May; 10(5):6028-6044. PubMed ID: 33440982
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Body Radiotherapy for Recurrent or Oligometastatic Uterine Cervix Cancer: A Cooperative Study of the Korean Radiation Oncology Group (KROG 14-11).
Park HJ; Chang AR; Seo Y; Cho CK; Jang WI; Kim MS; Choi C
Anticancer Res; 2015 Sep; 35(9):5103-10. PubMed ID: 26254414
[TBL] [Abstract][Full Text] [Related]
24. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
25. Emergence of stereotactic body radiation therapy.
Behrend SW
Oncol Nurs Forum; 2015 Jan; 42(1):103-4. PubMed ID: 25542328
[TBL] [Abstract][Full Text] [Related]
26. Stereotactic body radiotherapy for the treatment of oligometastatic renal cell carcinoma.
Ranck MC; Golden DW; Corbin KS; Hasselle MD; Liauw SL; Stadler WM; Hahn OM; Weichselbaum RR; Salama JK
Am J Clin Oncol; 2013 Dec; 36(6):589-95. PubMed ID: 22868242
[TBL] [Abstract][Full Text] [Related]
27. Patterns of recurrence after curative-intent radiation for oligometastases confined to one organ.
Milano MT; Katz AW; Okunieff P
Am J Clin Oncol; 2010 Apr; 33(2):157-63. PubMed ID: 19770627
[TBL] [Abstract][Full Text] [Related]
28. New concepts and insights into the role of radiation therapy in extracranial metastatic disease.
Ricardi U; Filippi AR; Franco P
Expert Rev Anticancer Ther; 2013 Oct; 13(10):1145-55. PubMed ID: 24134418
[TBL] [Abstract][Full Text] [Related]
29. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation.
Jawad MS; Fahim DK; Gerszten PC; Flickinger JC; Sahgal A; Grills IS; Sheehan J; Kersh R; Shin J; Oh K; Mantel F; Guckenberger M;
J Neurosurg Spine; 2016 Jun; 24(6):928-36. PubMed ID: 26895526
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcomes of single dose stereotactic radiotherapy for lung metastases.
Osti MF; Carnevale A; Valeriani M; De Sanctis V; Minniti G; Cortesi E; Martelli M; Maurizi Enrici R
Clin Lung Cancer; 2013 Nov; 14(6):699-703. PubMed ID: 23886798
[TBL] [Abstract][Full Text] [Related]
31. Stereotactic body radiation therapy for oligometastases.
Lo SS; Teh BS; Mayr NA; Olencki TE; Wang JZ; Grecula JC; Lu JJ; Timmerman RD
Discov Med; 2010 Sep; 10(52):247-54. PubMed ID: 20875346
[TBL] [Abstract][Full Text] [Related]
32. Stereotactic Body Radiotherapy for Oligometastasis: Opportunities for Biology to Guide Clinical Management.
Correa RJ; Salama JK; Milano MT; Palma DA
Cancer J; 2016; 22(4):247-56. PubMed ID: 27441744
[TBL] [Abstract][Full Text] [Related]
33. The role of stereotactic ablative radiotherapy (SBRT) in the management of oligometastatic non small cell lung cancer.
Guerrero E; Ahmed M
Lung Cancer; 2016 Feb; 92():22-8. PubMed ID: 26775592
[TBL] [Abstract][Full Text] [Related]
34. The Evolution (and Future) of Stereotactic Body Radiotherapy in the Treatment of Oligometastatic Disease.
Onderdonk BE; Gutiontov SI; Chmura SJ
Hematol Oncol Clin North Am; 2020 Feb; 34(1):307-320. PubMed ID: 31739951
[TBL] [Abstract][Full Text] [Related]
35. Stereotactic body radiation therapy: A promising chance for oligometastatic breast cancer.
Scorsetti M; Franceschini D; De Rose F; Comito T; Villa E; Iftode C; Navarria P; D'Agostino GR; Masci G; Torrisi R; Testori A; Tinterri C; Santoro A
Breast; 2016 Apr; 26():11-7. PubMed ID: 27017237
[TBL] [Abstract][Full Text] [Related]
36. Stereotactic body radiotherapy for oligoprogressive cancer.
Cheung P
Br J Radiol; 2016 Oct; 89(1066):20160251. PubMed ID: 27556349
[TBL] [Abstract][Full Text] [Related]
37. Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases: An International Survey of >1000 Radiation Oncologists.
Lewis SL; Porceddu S; Nakamura N; Palma DA; Lo SS; Hoskin P; Moghanaki D; Chmura SJ; Salama JK
Am J Clin Oncol; 2017 Aug; 40(4):418-422. PubMed ID: 25647831
[TBL] [Abstract][Full Text] [Related]
38. The role of radiation therapy in the modern management of oligometastatic disease.
Li Y; Tao S; Li M; Li D
J BUON; 2017; 22(4):831-837. PubMed ID: 29155507
[TBL] [Abstract][Full Text] [Related]
39. Descriptive analysis of oligometastatic lesions treated with curative-intent stereotactic body radiotherapy.
Milano MT; Katz AW; Schell MC; Philip A; Okunieff P
Int J Radiat Oncol Biol Phys; 2008 Dec; 72(5):1516-22. PubMed ID: 18495378
[TBL] [Abstract][Full Text] [Related]
40. Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease.
Salama JK; Hasselle MD; Chmura SJ; Malik R; Mehta N; Yenice KM; Villaflor VM; Stadler WM; Hoffman PC; Cohen EE; Connell PP; Haraf DJ; Vokes EE; Hellman S; Weichselbaum RR
Cancer; 2012 Jun; 118(11):2962-70. PubMed ID: 22020702
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
